SUBSCRIBE
SUBSCRIBE
News   Business

EpiCept Corporation’s Board of Directors Appoints New Independent Member

April 28, 2011 | 
1 min read
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today the appointment of Keith L. Brownlie, former partner of Ernst & Young LLP, to its Board of Directors.
People
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
March 4, 2026
 · 
61 min read
 · 
BioSpace Editorial Staff
Halftone hands reaching for money. Mixed media catch falling coins and cash bills collage, financial success, free wealth and easy money concept vector illustration
Earnings
Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground
March 4, 2026
 · 
9 min read
 · 
Tristan Manalac
Set of crumpled lumps of different paper isolated on yellow background. Gritty dusty dotted effect, vector elements with jagged edges, old notebook sheets.
MASH
Boehringer Ingelheim Axes MASH Pact With OSE After Disappointing Mid-Stage Data
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration showing line of people leaving, standing on top of hand pointing their way out
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
 · 
1 min read
 · 
Angela Gabriel